CastleKnight Management’s Medifast MED Stock Holding History

CastleKnight Management’s Portfolio MED Stock Details MED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-9,050	Closed	-$834K	–	341
2023 Q2	$834K	Hold	9,050	–	–	0.17%	148
2023 Q1	$938K	Hold	9,050	–	–	0.24%	139
2022 Q4	$1.04M	Hold	9,050	–	–	0.3%	96
2022 Q3	$981K	Buy	9,050 +1,250	+16%	+$179K	0.31%	92
2022 Q2	$1.41M	Buy	7,800 +4,400	+129%	+$787K	0.44%	75
2022 Q1	$581K	Buy	+3,400	New	+$641K	0.16%	161

Other funds holding MED

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Pacer Advisors Malvern, Pennsylvania $34.9B AUM 18.19% 1-Year Est. Return

Citadel Advisors

Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return

First Trust Advisors

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Geode Capital Management

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return